Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayer B Davidson

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Diabetes Care|October 4, 2012
High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis DMayer B Davidson, Petra Duran, Martin L Lee, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 18, 2011
A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failureMayer B Davidson, Philip Raskin, Robert J Tanenberg, et al.
Diabetes Care|May 27, 2003
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetesMichael Brandle, Mayer B Davidson, David L Schriger, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2011
Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitusStanley H Hsia, Maria D Navar, Petra Duran, et al.
American Journal of Nephrology|April 17, 2004
ImmunoDip: an improved screening method for microalbuminuriaMayer B Davidson, Mohsen Bazargan, George Bakris, et al.
Journal of Diabetes and Its Complications|December 13, 2002
Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot studyRita Pradhan, Donald Fong, Cabrini March, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2008
A new look at screening and diagnosing diabetes mellitusChristopher D Saudek, William H Herman, David B Sacks, et al.
Diabetes Care|January 1, 2008
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetes Care|October 24, 2008
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Current Trends in Internal Medicine|March 5, 2025
An Effective Straightforward Protocol for the Treatment of Graves' Hyperthyroidism for Primary Care ProvidersFelisha Eugenio, Syed M Kazim Raza, Ishmum Hasan, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Diabetes Care|October 4, 2012
High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis DMayer B Davidson, Petra Duran, Martin L Lee, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 18, 2011
A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failureMayer B Davidson, Philip Raskin, Robert J Tanenberg, et al.
Diabetes Care|May 27, 2003
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetesMichael Brandle, Mayer B Davidson, David L Schriger, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 10, 2011
Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitusStanley H Hsia, Maria D Navar, Petra Duran, et al.
American Journal of Nephrology|April 17, 2004
ImmunoDip: an improved screening method for microalbuminuriaMayer B Davidson, Mohsen Bazargan, George Bakris, et al.
Journal of Diabetes and Its Complications|December 13, 2002
Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot studyRita Pradhan, Donald Fong, Cabrini March, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2008
A new look at screening and diagnosing diabetes mellitusChristopher D Saudek, William H Herman, David B Sacks, et al.
Diabetes Care|January 1, 2008
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Diabetes Care|October 24, 2008
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesDavid M Nathan, John B Buse, Mayer B Davidson, et al.
Current Trends in Internal Medicine|March 5, 2025
An Effective Straightforward Protocol for the Treatment of Graves' Hyperthyroidism for Primary Care ProvidersFelisha Eugenio, Syed M Kazim Raza, Ishmum Hasan, et al.
Pageof 15